Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis

Archives of Neurology

Volumn 57, Issue 4, 2000, Pages 520-524

  Verrips, Aad ^a   Van Engelen, Baziel G M ^a   Wevers, Ron A ^a   Van Geel, Björn M ^b   Cruysberg, Johannes R M ^a   Van Den Heuvel, Lambert P W J ^a   Keyser, Antoine ^a   Gabreëls, Fons J M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTANOL;

ACHILLES TENDON; ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CATARACT; CEREBROTENDINOUS XANTHOMATOSIS; CLINICAL ARTICLE; DIARRHEA; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; MALE; PRIORITY JOURNAL; SCREENING TEST;

EID: 0034036188     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.57.4.520     Document Type: Article

References (22)

1. Van Bogaert L, Scherer H, Epstein E. Une forme cérébrale de la cholestérinose généralisée. Paris, France: Masson et Cie: 1937.
2. Verrips A, Lycklama-à-Nijeholt GJ, Barkhof F, et al. Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis. Brain2E 1999;122:1589-1595.
3. Cruysberg JR, Wevers RA, Tolboom JJ. Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis. Am J Ophthalmol. 1991; 112:606-607.
4. Van Heijst AFJ, Verrips A, Wevers RA, Cruysberg JRM, Renier WO, Tolboom JJM. Treatment and follow-up of children with cerebrotendinous xanthomatosis. Eur J Pediatr. 1998;157:313-316.
5. Salen G, Meriwether TW, Nicolau G. Chenodeoxycholic acid inhibits increased cholesterol and cholestanol synthesis in patients with cerebrotendinous xanthomatosis. Biochem Med. 1975;14:57-74.
6. Berginer VM, Salen G, Shefer S. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med. 1984;311:1649-1652.
7. Verrips A, Wevers RA, Van Engelen BG, et al. Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis. Metabolism. 1999;48:233-238.
8. Wolthers BG, Volmer M, van der Molen J, Koopman BJ, de Jager AE, Waterreus RJ. Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography. Clin Chim Acta. 1983;131:53-65.
9. Koopman BJ, van der Molen JC, Wolthers BG, de Jager AE, Waterreus RJ, Gips CH. Capillary gas chromatographic determination of cholestanol/cholesterol ratio in biological fluids: its potential usefulness for the follow-up of some liver diseases and its lack of specificity in diagnosing CTX (cerebrotendinous xanthomatosis). Clin Chim Acta. 1984;137:305-315.
10. Luyten JAFM, Wenink PW, Steenbergen-Spanjers GCH, et al. Metachromatic leukodystrophy: a 12-bp deletion in exon 2 of the arylsulfatase A gene in the late infantile variant. Hum Genet. 1995;96:357-360.
11. Leitersdorf E, Reshef A, Meiner V, et al. Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews of Moroccan origin. J Clin Invest 1993;91:2488-2496.
12. Cali JJ, Russell DW. Characterization of human sterol 27-hydroxylase. J Biol Chem. 1991;266:7774-7778.
13. Segev H, Reshef A, Clavey V, Delbart C, Routier G, Leitersdorf E. Premature termination codon at the sterol 27-hydroxylase gene causes cerebrotendinous xanthomatosis in a French family. Hum Genet. 1995;95:238-240.
14. Verrips A, Steenbergen-Spanjers GCH, Luyten JAFM, et al. Two new mutations in the sterol 27-hydroxylase gene in two families lead to cerebrotendinous xanthomatosis. Hum Genet. 1996;98:735-737.
15. Ahmed MS, Afsar S, Hentati A, et al. A novel mutation in the sterol 27-hydroxylase gene of a Pakistani family with autosomal recessive cerebrotendinous xanthomatosis. Neurology. 1997;48:258-260.
16. Verrips A, Steenbergen-Spanjers GCH, Luyten JAFM, et al. Exon skipping in the sterol 27-hydroxylase gene leads to cerebrotendinous xanthomatosis. Hum Genet. 1997;100:284-286.
17. Meiner V, Meiner Z, Reshef A, Björkhem I, Leitersdorf E. Cerebrotendinous xanthomatosis: molecular diagnosis enables presymptomatic detection of a treatable disease. Neurology. 1994;44:288-290.
18. Reshef A, Meiner V, Berginer VM, Leitersdorf E. Molecular genetics of cerebrotendinous xanthomatosis in Jews of north African origin. J Lipid Res. 1994;35: 478-483.
19. Cali JJ, Hsieh CL, Francke U, Russell DW. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem. 1991;266:7779-7783.
20. Garuti R, Croce A, Tiozzo R, et al. Four novel mutations of sterol 27-hydroxylase gene in Italian patients with cerebrotendinous xanthomatosis. J Lipid Res. 1997; 38:2322-2334.
21. Van Heijst AFJ, Wevers RA, Tangerman A, Cruysberg JRM. Chronic diarrhoea as a dominating symptom in two children. Acta Paediatr. 1996;85:932-936.
22. Siebner HR, Berndt S, Conrad B. Cerebrotendinous xanthomatosis without tendon xanthomas mimicking Marinesco-Sjoegren syndrome: a case report. J Neurol Neurosurg Psychiatry. 1996;60:582-585.